Series A Biotechnology Companies

Renewal Mill is a next generation ingredients company that upcycles byproducts from food manufacturing into high-quality ingredients.

eXmoor Pharma is a technical and strategic consultancy specialising in cell and gene therapies (ATMPs) and biopharmaceuticals.

Pluton Biosciences tests and discovers microbes for the production of a variety of products, primarily pesticides, and pharmaceuticals.

ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.

Larkspur Biosciences is a biotechnology business that is developing the next generation of precision immunotherapies to combat cancer.

Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.

Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials.

NewBiologix operates as a technology innovation company.

DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.

ChrysaLabs develops a real-time, portable and accurate soil fertility assessment technology for precision agriculture

Delta Diagnostics is a biotech company that creates highly sensitive and selective biosensors using integrated photonics.

Ronawk develops a T-Block technology producing patient-specific biologics to treat diseases, cancer, organ injuries, and burns.

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

Xsphera Biosciences is a biotechnology startup that focuses on delivering functional, precision immuno-oncology solutions.

Democratizing access to brain stroke treatment

Initial Therapeutics is a developer of small-molecule medicines designed to prevent pathogenic protein synthesis.

Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.

Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases

Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.

Complement Therapeutics operates as a preclinical stage company.

Upkara operates as a biotechnology company that specializes in developing biopreservation technologies.

Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.

D2M Biotherapeutics focuses on the development of novel immunotherapeutics.

Medical technology startup company specializing in large bore vascular closure following transcatheter cardiovascular therapies

Capacity Bio is a therapeutics company that is focused on mitophagy.